India's Zydus Cadila seeks human trial approval for COVID-19 antibody cocktail

Regeneron and Roche's antibody cocktail has also received emergency use approval in India, and will be distributed by drugmaker Cipla. The first batch of the cocktail became available in the country earlier this week.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3bYtH0d
via IFTTT

0 comments:

Post a Comment